MRI-Guided radiation zaps tumors with pinpoint accuracy
NCT ID NCT05903430
First seen Oct 31, 2025 · Last updated May 23, 2026 · Updated 31 times
Summary
This study is testing whether doctors can deliver very focused, high-dose radiation to tumors in the abdomen or chest while limiting damage to nearby healthy organs. The approach uses a special MRI machine combined with a linear accelerator (MR-Linac) to guide the radiation in real time. About 60 adults with abdominal or lung cancer will take part. The main goal is to see if the treatment can be delivered successfully in more than 85% of cases.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
The Christie NHS Foundation Trust
RECRUITINGManchester, United Kingdom, M204BX, United Kingdom
Conditions
Explore the condition pages connected to this study.